Thank you for visiting us
Moletest Limited has created a medical device that runs on ios devices designed for use by Medical Professionals. It is called, nomela®.

It assesses risk of malignancy for a pigmented skin lesion (mole) to reduce unneeded referrals safely.

Why you need
Nearly 97% of skin lesion referrals are unnecessary.

This is caused by over-dependence on subjective examination and answers to clinical questions.
Moletest's nomela® has been developed to help medical professionals assess skin lesions more effectively and so avoid unneeded referrals.
To provide GPs with a simple risk assessment tool to screen out non-malignant lesions efficiently and reliably.

To provide effective referral information to enable comparative analysis and appropriate treatment.
What is
Our Objectives
Contact Us
Made with HTML Egg on a Mac
© Moletest Limited